Skip to main content
Clinical Trials/NCT01558596
NCT01558596
Completed
Phase 1

Cardiac Remote Ischemic Preconditioning Prior to Elective Major Vascular Surgery

VA Office of Research and Development1 site in 1 country201 target enrollmentSeptember 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Peripheral Arterial Disease
Sponsor
VA Office of Research and Development
Enrollment
201
Locations
1
Primary Endpoint
Troponin I Elevation Above the Upper Reference Limit (URL)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The investigators have previously shown that elective vascular surgery is a high-risk operation with an anticipated risk of either death or heart attack of 15%. This study is testing whether a protocol of remote ischemic preconditioning (RIPC) applied 24 hours prior to the operation is safe, feasible and reduces the incidence of an adverse, perioperative cardiac complication.

Detailed Description

The proposed investigation has a single blind, randomized design and plans to enroll 180-205 patients who are scheduled to have major, elective vascular surgery for occlusive carotid disease, expanding abdominal aortic aneurysm (AAA), occlusive lower extremity disease and/or critical limb ischemia at the Minneapolis VA Health Care Center. 24 hours prior to the patient's scheduled vascular operation, RIPC therapy will be applied to one of the participant's upper arms to cause forearm ischemia. Clinically collected, pre-operative troponins, creatine kinase MBs (CK-MBs), EKGs along with troponins, CK-MBs and EKGs collected on day 1, 2, 3 and day 7 (if still hospitalized) will be utilized to evaluate the occurrence of perioperative, adverse cardiac events.

Registry
clinicaltrials.gov
Start Date
September 2011
End Date
September 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Undergoing elective major vascular surgery at the Minneapolis VA Medical Center for abdominal aortic aneurysm, carotid disease or limb ischemia.
  • Provides informed consent.

Exclusion Criteria

  • Hypertensive crisis
  • Peripheral arterial disease of the upper extremities
  • Arteriovenous (AV) fistula
  • Acute Coronary Syndrome (ACS) in the last 6 months
  • Severe valvular heart disease
  • Pregnant women
  • Unable to provide consent

Outcomes

Primary Outcomes

Troponin I Elevation Above the Upper Reference Limit (URL)

Time Frame: Within 3 days of the vascular operation

Troponin I is a biomarker of myocardial necrosis that may indicate myocardial damage or injury that occurs during the perioperative period

Study Sites (1)

Loading locations...

Similar Trials